• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

对《MEIS2通过靶向TAL1调控人胚胎干细胞的内皮向造血转变》一文的更正

Correction to: MEIS2 regulates endothelial to hematopoietic transition of human embryonic stem cells by targeting TAL1.

作者信息

Wang Mengge, Wang Hongtao, Wen Yuqi, Chen Xiaoyuan, Liu Xin, Gao Jie, Su Pei, Xu Yuanfu, Zhou Wen, Shi Lihong, Zhou Jiaxi

机构信息

State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Tianjin, 300020, China.

Center for Stem Cell Medicine, Chinese Academy of Medical Sciences and Department of Stem Cells and Regenerative Medicine, Peking Union Medical College, Tianjin, 300020, China.

出版信息

Stem Cell Res Ther. 2020 Oct 19;11(1):446. doi: 10.1186/s13287-020-01913-2.

DOI:10.1186/s13287-020-01913-2
PMID:33076973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7574475/
Abstract

An amendment to this paper has been published and can be accessed via the original article.

摘要

本文的一个修订版本已发表，可通过原始文章获取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355e/7574475/4e5af5a90745/13287_2020_1913_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355e/7574475/4e5af5a90745/13287_2020_1913_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/355e/7574475/4e5af5a90745/13287_2020_1913_Fig1_HTML.jpg

相似文献

1
Correction to: MEIS2 regulates endothelial to hematopoietic transition of human embryonic stem cells by targeting TAL1.对《MEIS2通过靶向TAL1调控人胚胎干细胞的内皮向造血转变》一文的更正
Stem Cell Res Ther. 2020 Oct 19;11(1):446. doi: 10.1186/s13287-020-01913-2.
2
Correction to: MSX2 suppression through inhibition of TGFβ signaling enhances hematopoietic differentiation of human embryonic stem cells.对《通过抑制TGFβ信号通路抑制MSX2增强人胚胎干细胞的造血分化》的更正
Stem Cell Res Ther. 2020 Jun 17;11(1):242. doi: 10.1186/s13287-020-01760-1.
3
Correction to: Matrix metalloproteinase 9 induces endothelial-mesenchymal transition via Notch activation in human kidney glomerular endothelial cells.对《基质金属蛋白酶9通过激活Notch信号通路诱导人肾小球内皮细胞发生内皮-间充质转化》一文的更正
BMC Mol Cell Biol. 2020 Oct 21;21(1):72. doi: 10.1186/s12860-020-00318-6.
4
Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse.Flk1和Tal1对小鼠血管和造血发育的联合作用。
Genes Dev. 2003 Feb 1;17(3):380-93. doi: 10.1101/gad.1049803.
5
Correction to: Roles of microRNA-34a targeting SIRT1 in mesenchymal stem cells.对《间充质干细胞中靶向SIRT1的微小RNA-34a的作用》的更正
Stem Cell Res Ther. 2020 Jul 31;11(1):331. doi: 10.1186/s13287-020-01854-w.
6
The SCL/TAL1 Transcription Factor Represses the Stress Protein DDiT4/REDD1 in Human Hematopoietic Stem/Progenitor Cells.SCL/TAL1 转录因子抑制人造血干/祖细胞中的应激蛋白 DDiT4/REDD1。
Stem Cells. 2015 Jul;33(7):2268-79. doi: 10.1002/stem.2028. Epub 2015 May 25.
7
Expression of the TAL1/SCL transcription factor in physiological and pathological vascular processes.TAL1/SCL转录因子在生理和病理血管过程中的表达
J Pathol. 2006 Sep;210(1):121-9. doi: 10.1002/path.2028.
8
Efficient and repetitive production of hematopoietic and endothelial cells from feeder-free monolayer culture system of primate embryonic stem cells.从灵长类胚胎干细胞无饲养层单层培养系统高效且重复地生产造血细胞和内皮细胞。
Biol Reprod. 2006 Feb;74(2):295-306. doi: 10.1095/biolreprod.105.043331. Epub 2005 Oct 12.
9
Transcription factor SCL/TAL1 mediates the phosphorylation of MEK/ERK pathway in umbilical cord blood CD34⁺ stem cells during hematopoietic differentiation.转录因子SCL/TAL1在造血分化过程中介导脐带血CD34⁺干细胞中MEK/ERK途径的磷酸化。
Blood Cells Mol Dis. 2014 Jun-Aug;53(1-2):39-46. doi: 10.1016/j.bcmd.2013.12.007. Epub 2014 Jan 7.
10
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells.作者更正：长期造血干细胞中X连锁重症联合免疫缺陷病（SCID-X1）的基因校正。
Nat Commun. 2019 Dec 4;10(1):5624. doi: 10.1038/s41467-019-13620-5.

引用本文的文献

1
Systematic review of exosomes derived from various stem cell sources: function and therapeutic potential in disease modulation.来自不同干细胞来源的外泌体的系统评价：在疾病调节中的功能和治疗潜力
Mol Biol Rep. 2025 Aug 23;52(1):842. doi: 10.1007/s11033-025-10943-z.
2
Administration of mesenchymal stem cells in diabetic kidney disease: mechanisms, signaling pathways, and preclinical evidence.间充质干细胞在糖尿病肾病中的应用：机制、信号通路和临床前证据。
Mol Cell Biochem. 2022 Aug;477(8):2073-2092. doi: 10.1007/s11010-022-04421-4. Epub 2022 Apr 25.

本文引用的文献

1
MEIS2 regulates endothelial to hematopoietic transition of human embryonic stem cells by targeting TAL1.MEIS2 通过靶向 TAL1 调节人胚胎干细胞的内皮向造血转化。
Stem Cell Res Ther. 2018 Dec 7;9(1):340. doi: 10.1186/s13287-018-1074-z.